Matches in Nanopublications for { ?s ?p "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- _4 value "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" provenance.
- _4 value "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" provenance.
- _4 value "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" provenance.
- _4 value "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" provenance.
- _4 value "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" provenance.
- _5 value "PPARG agonists may decrease inflammatory functions of macrophages and VSMC, and in vivo administration of PPARG agonists to atherosclerosis-prone mice reduces both lesion size and MMP expression, indicating plaque-stabilizing effects (95, 101)" provenance.